PF-04957325 , CAS No.1305115-80-3, Inhibitor of phosphodiesterase 8A

Item Number
P612731
Grouped product items
SKUSizeAvailabilityPrice Qty
P612731-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,334.90
P612731-25mg
25mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$2,001.90
View related series
phosphodiesterase 8A Inhibitor

Basic Description

Specifications & PurityMoligand™
GradeMoligand™
Action TypeINHIBITOR
Mechanism of actionInhibitor of phosphodiesterase 8A

Associated Targets(Human)

PDE8A Tclin High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Associated Targets(non-human)

Pde8a Phosphodiesterase 8A (1 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Names and Identifiers

IUPAC Name 3-[[(2R)-4-(1,3-thiazol-2-ylmethyl)morpholin-2-yl]methyl]-5-(trifluoromethyl)triazolo[4,5-d]pyrimidin-7-amine
INCHI InChI=1S/C14H15F3N8OS/c15-14(16,17)13-20-11(18)10-12(21-13)25(23-22-10)6-8-5-24(2-3-26-8)7-9-19-1-4-27-9/h1,4,8H,2-3,5-7H2,(H2,18,20,21)/t8-/m1/s1
InChi Key VNLPYEMGHGDRRZ-MRVPVSSYSA-N
Canonical SMILES C1COC(CN1CC2=NC=CS2)CN3C4=NC(=NC(=C4N=N3)N)C(F)(F)F
Isomeric SMILES C1CO[C@H](CN1CC2=NC=CS2)CN3C4=NC(=NC(=C4N=N3)N)C(F)(F)F
PubChem CID 52938379

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Related Documents

References

1. Maurice DH, Ke H, Ahmad F, Wang Y, Chung J, Manganiello VC.  (2014)  Advances in targeting cyclic nucleotide phosphodiesterases..  Nat Rev Drug Discov,  13  (4): (290-314).  [PMID:24687066] [10.1021/op500134e]
2. Basole CP, Nguyen RK, Lamothe K, Vang A, Clark R, Baillie GS, Epstein PM, Brocke S.  (2017)  PDE8 controls CD4+ T cell motility through the PDE8A-Raf-1 kinase signaling complex..  Cell Signal,  40  (13): (62-72).  [PMID:28851628] [10.1021/op500134e]

Solution Calculators